Skip to content
Catalyst

PapersPMID:26934084

Supplementation with Watermelon Extract Reduces Total Cholesterol and LDL Cholesterol in Adults with Dyslipidemia under the Influence of the MTHFR C677T Polymorphism.

Journal of the American College of Nutrition2016The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, very limited evidencelowersTotal cholesterol (TC)
  2. Finding, very limited evidencelowersLDL cholesterol
Study, every finding
RCT · 6 weeks
Dose studied, every finding
6 g watermelon extract daily for 42 days
Population, every finding
adults with dyslipidemia
  • “The use of watermelon extract reduced plasma total cholesterol (p < 0.05) and low-density lipoprotein (p < 0.01) without modifying triglycerides, high-density lipoprotein, and very low-density lipoprotein values.”

Study record

Design
randomised controlled trial
Species
human
Population
Adults with dyslipidemia, phase II randomized double-blind trial of 6 g/day watermelon extract (Citrullus lanatus) versus a carbohydrate mixture (sucrose/glucose/fructose) for 42 days, stratified by MTHFR C677T genotype. Exposure is a watermelon extract, not juice or puree. Abstract only.
Participants
43
Comparator
placebo
Duration
42 days
Endpoints measured
7